Bellevue Free Cash Flow Operating Cash Flow Ratio from 2010 to 2024
| BLAC Stock | 11.26 0.13 1.17% |
Free Cash Flow Operating Cash Flow Ratio | First Reported 2010-12-31 | Previous Quarter 0.9 | Current Value 0.8 | Quarterly Volatility 0.05606281 |
Check Bellevue Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bellevue Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 167.8 K, Other Operating Expenses of 1.9 M or EBIT of 815.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.72. Bellevue financial statements analysis is a perfect complement when working with Bellevue Life Valuation or Volatility modules.
Bellevue | Free Cash Flow Operating Cash Flow Ratio |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bellevue Life Sciences is a strong investment it is important to analyze Bellevue Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bellevue Life's future performance. For an informed investment choice regarding Bellevue Stock, refer to the following important reports:Check out the analysis of Bellevue Life Correlation against competitors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellevue Life. If investors know Bellevue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellevue Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Return On Assets (0.03) |
The market value of Bellevue Life Sciences is measured differently than its book value, which is the value of Bellevue that is recorded on the company's balance sheet. Investors also form their own opinion of Bellevue Life's value that differs from its market value or its book value, called intrinsic value, which is Bellevue Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellevue Life's market value can be influenced by many factors that don't directly affect Bellevue Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellevue Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bellevue Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellevue Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.